This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Apo-Atorvastatin FCT 40 mg

Starting date:
July 23, 2013
Posting date:
August 9, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-34925

Recalled products

  1. Apo-Atorvastatin FCT 40 mg

Reason

The impacted lot may have come into contact with metal and/or food-grade lubricant during manufacturing.

Depth of distribution

Wholesalers, pharmacies.  Distribution in most of Canada.

Affected products

A. Apo-Atorvastatin FCT 40 mg

DIN, NPN, DIN-HIM
DIN 02295296
Dosage form

Tablet

Strength
  • 40 mg
Lot or serial number
  • KA2901
Companies
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: